Literature DB >> 10972984

Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer.

I Alberti1, P Barboro, M Barbesino, P Sanna, L Pisciotta, S Parodi, G Nicolò, F Boccardo, S Galli, E Patrone, C Balbi.   

Abstract

The nuclear matrix-intermediate filament complex (NM-IF) is a protein scaffold which spans the whole cell, and several lines of evidence suggest that this structural frame represents also a functional unit, which could be involved in the epigenetic control of cancer development. Here we report the characterization by high resolution two-dimensional gel electrophoresis and Western blot analysis of the NM-IF complex isolated from prostate cancer (PCa); tumor-associated proteins were identified by comparing the electrophoretic patterns with those of normal human prostate (NHP). Extensive changes in the expression of both the NM and IF proteins occur; they are, however, related in a different way to tumor progression. Poorly differentiated PCa (Gleason score 8-9) shows a strong down regulation of several constitutive cytokeratins (CKs 8, 18, and 19); their expression significantly (P < 0.05) decreases with respect to both NHP and benign prostatic hyperplasia (BPH) and, more interestingly, also with respect to moderately (Gleason score 6-7) and well (Gleason score 4-5) differentiated tumors. Moreover, we have identified a tumor-associated species which is present in all of the tumors examined, systematically absent in NHP and occurs only in a few samples of BPH; this polypeptide, of M(r) 48,000 and pI 6.0, represent a proteolytic fragment of CK8. At variance with these continuing alterations in the expression, the NM proteins undergo stepwise changes correlating with the level of differentiation. The development of less differentiated tumors is characterized by the appearance of several new proteins and by the decrease in the expression of others. Six proteins were found to be expressed with a frequency equal to one in poorly differentiated tumor, namely in all the samples of tumor examined, while in moderately and well differentiated tumors the frequency is less than one, and decreases with increasing the level of differentiation. When tumors of increasing Gleason score are compared with NHP a dramatic increase in the complexity of the protein patterns is observed, indicating that tumor dedifferentiation results in a considerable increase in the phenotypic diversity. These results suggest that tumor progression can be characterized using an appropriate subset of tumor-associated NM proteins. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972984

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system.

Authors:  John D Lapek; James L McGrath; William A Ricke; Alan E Friedman
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-03-03       Impact factor: 3.205

2.  Prognostic value of nuclear matrix protein expression in localized prostate cancer.

Authors:  Francesco Ricci; Alessandra Rubagotti; Linda Zinoli; Rosa Mangerini; Pier Vitale Nuzzo; Giorgio Carmignani; Alchiede Simonato; Paola Barboro; Cecilia Balbi; Francesco Boccardo
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-10       Impact factor: 4.553

3.  Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation.

Authors:  Jian Tang; Jing-Wen Niu; Dong-Hui Xu; Zhi-Xing Li; Qi-Fu Li; Jin-An Chen
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

4.  Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.

Authors:  Tarek G Gharib; Guoan Chen; Hong Wang; Chiang-Ching Huang; Michael S Prescott; Kerby Shedden; David E Misek; Dafydd G Thomas; Thomas J Giordano; Jeremy M G Taylor; Sharon Kardia; John Yee; Mark B Orringer; Samir Hanash; David G Beer
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

5.  Serum early prostate cancer antigen (EPCA) level and its association with disease progression in prostate cancer in a Chinese population.

Authors:  Zhigang Zhao; Wenjing Ma; Guohua Zeng; Defeng Qi; Lili Ou; Yeping Liang
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

6.  Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.

Authors:  P Barboro; E Repaci; A Rubagotti; S Salvi; S Boccardo; B Spina; M Truini; C Introini; P Puppo; N Ferrari; G Carmignani; F Boccardo; C Balbi
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

7.  Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells.

Authors:  Paola Barboro; Luana Borzì; Erica Repaci; Nicoletta Ferrari; Cecilia Balbi
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 8.  Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management.

Authors:  Nigel P Murray
Journal:  Biol Res       Date:  2018-09-04       Impact factor: 5.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.